Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

Karin Purshouse; John P Thomson; Mahéva Vallet; Lorna Alexander; Isaac Bonisteel; Maree Brennan; David A. Cameron; Jonine Figueroa; Elizabeth Furrie; Pamela Haig; Mattea Heck; Hugh McCaughan; Paul Mitchell; Heather McVicars; Lorraine Primrose; Kate Templeton; Natalie Wilson; Peter S. Hall

doi:10.1200/JCO.2022.40.16_suppl.e18733

Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

Karin Purshouse, John P Thomson, Mahéva Vallet, Lorna Alexander, Isaac Bonisteel, Maree Brennan, David A. Cameron, Jonine Figueroa, Elizabeth Furrie, Pamela Haig, Mattea Heck, Hugh McCaughan, Paul Mitchell, Heather McVicars, Lorraine Primrose, Kate Templeton, Natalie Wilson, Peter S. Hall

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	e18733
Journal	Journal of Clinical Oncology
Volume	40
Issue number	16_suppl
DOIs	https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733
Publication status	Published - 1 Jun 2022

Access to Document

10.1200/JCO.2022.40.16_suppl.e18733

https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.e18733

Cite this

Purshouse, K., Thomson, J. P., Vallet, M., Alexander, L., Bonisteel, I., Brennan, M., Cameron, D. A., Figueroa, J., Furrie, E., Haig, P., Heck, M., McCaughan, H., Mitchell, P., McVicars, H., Primrose, L., Templeton, K., Wilson, N., & Hall, P. S. (2022). Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic. Journal of Clinical Oncology, 40(16_suppl), Article e18733. https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733

@article{b13864af9bee4f93b3e626032dec07f4,

title = "Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.",

author = "Karin Purshouse and Thomson, {John P} and Mah{\'e}va Vallet and Lorna Alexander and Isaac Bonisteel and Maree Brennan and Cameron, {David A.} and Jonine Figueroa and Elizabeth Furrie and Pamela Haig and Mattea Heck and Hugh McCaughan and Paul Mitchell and Heather McVicars and Lorraine Primrose and Kate Templeton and Natalie Wilson and Hall, {Peter S.}",

year = "2022",

month = jun,

day = "1",

doi = "10.1200/JCO.2022.40.16_suppl.e18733",

language = "English",

volume = "40",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "16_suppl",

}

Purshouse, K , Thomson, JP , Vallet, M, Alexander, L, Bonisteel, I, Brennan, M, Cameron, DA , Figueroa, J, Furrie, E, Haig, P, Heck, M, McCaughan, H , Mitchell, P, McVicars, H, Primrose, L, Templeton, K, Wilson, N & Hall, PS 2022, 'Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.', Journal of Clinical Oncology, vol. 40, no. 16_suppl, e18733. https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733

Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic. / Purshouse, Karin ; Thomson, John P ; Vallet, Mahéva et al.
In: Journal of Clinical Oncology, Vol. 40, No. 16_suppl, e18733, 01.06.2022.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

AU - Purshouse, Karin

AU - Thomson, John P

AU - Vallet, Mahéva

AU - Alexander, Lorna

AU - Bonisteel, Isaac

AU - Brennan, Maree

AU - Cameron, David A.

AU - Figueroa, Jonine

AU - Furrie, Elizabeth

AU - Haig, Pamela

AU - Heck, Mattea

AU - McCaughan, Hugh

AU - Mitchell, Paul

AU - McVicars, Heather

AU - Primrose, Lorraine

AU - Templeton, Kate

AU - Wilson, Natalie

AU - Hall, Peter S.

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1200/JCO.2022.40.16_suppl.e18733

DO - 10.1200/JCO.2022.40.16_suppl.e18733

M3 - Meeting abstract

SN - 0732-183X

VL - 40

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16_suppl

M1 - e18733

ER -